title: Rapid regulation of neurite outgrowth and retraction by phospholipase A2-derived arachidonic acid and its metabolites.
abstract: Arachidonic acid and lipoxygenase metabolites have been proposed to act as retrograde synaptic messengers and as early mediators of neuronal injury, but few studies have analyzed their roles in controlling neurite behavior within a time window of minutes to hours. Phospholipase A2 inhibitors (BPB, ONO-RS-082, quinacrine and AACOCF3) and the lipoxygenase inhibitor AA861 delayed the initial outgrowth of NG108-15 cell neurites on laminin. Inhibitors of diacylglycerol lipase (RHC 80267), cyclooxygenase (indomethacin) and free radicals (N-acetyl cysteine and vitamin E) did not produce similar effects. Phospholipase A2 and lipoxygenase inhibitors also prevented acute neurite retraction in response to lysophosphatidic acid and eight other agents tested, and decreased F-actin staining at cell margins. Conversely, exogenous arachidonic acid (1 microM) enhanced the responses of neurites in outgrowth and retraction assays. Phospholipase A2 and lipoxygenase pathways appear to have a general role in maintaining the ability of neurites to respond rapidly to external stimuli, possibly via regulating the ability of the cytoskeleton to remodel.
authors.affiliation: Department of Pediatrics, University of Chicago, IL 60637, USA.
authors.forename: N R
authors.initials: NR
authors.lastname: Smalheiser
authors.forename: S
authors.initials: S
authors.lastname: Dissanayake
authors.forename: A
authors.initials: A
authors.lastname: Kapil
mesh_terms: D000199:Actins / Q000378:metabolism; D000975:Antioxidants / Q000494:pharmacology; D016718:Arachidonic Acid / Q000096:biosynthesis / Q000502:physiology*; D015536:Down-Regulation / Q000187:drug effects; D006651:Histocytochemistry; D007213:Indomethacin / Q000494:pharmacology; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D008246:Lysophospholipids / Q000494:pharmacology; D016501:Neurites / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D010084:Oxidation-Reduction; D010741:Phospholipases A / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D054467:Phospholipases A2; D011493:Protein Kinase C / Q000096:biosynthesis; D014407:Tumor Cells, Cultured
chemical_list: D000199:Actins; D000975:Antioxidants; D016859:Lipoxygenase Inhibitors; D008246:Lysophospholipids; D016718:Arachidonic Acid; D011493:Protein Kinase C; D010741:Phospholipases A; D054467:Phospholipases A2; D007213:Indomethacin